{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:42:02Z","timestamp":1774572122711,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T00:00:00Z","timestamp":1677196800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Research Grant of Doctoral School, Poznan University of Medical Sciences","award":["502-14-11121500-45047"],"award-info":[{"award-number":["502-14-11121500-45047"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to investigate the association between selected polymorphisms of nitric oxide synthetase (eNOS) and endothelin-1 (EDN-1) with the occurrence and progression of retinopathy of prematurity (ROP). A prospective study was conducted on 90 preterm infants (44 female), comparing 39 cases with ROP and 51 controls without ROP. Patients who developed ROP were further divided into two subgroups\u2014those with spontaneous regression of the disease and those with ROP requiring treatment. We found that preterm infants with TT genotype eNOS 894G\u2009&gt;\u2009T had a 12.8-fold higher risk of developing ROP requiring treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.02). Our results showed that allele T of eNOS894G\u2009&gt;\u2009T polymorphism was significantly more prevalent in ROP patients requiring treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.029). We also investigated preterm infants with TC genotype eNOS \u2212\u2009786 T\u2009&gt;\u2009C and found an 8.8-fold higher risk developing of ROP requiring treatment (<jats:italic>p<\/jats:italic>\u2009=\u20090.021). Our results didn\u2019t show any association between EDN-1 5665G\u2009&gt;\u2009T polymorphism and ROP development. The eNOS polymorphisms appears to influence incidence of ROP requiring treatment in preterm infants. Future research on single nucleotide polymorphisms may provide important information about the pathogenetic mechanisms underlying the development of ROP.<\/jats:p>","DOI":"10.1186\/s12886-023-02810-x","type":"journal-article","created":{"date-parts":[[2023,2,24]],"date-time":"2023-02-24T17:02:57Z","timestamp":1677258177000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Potential role of eNOS and EDN-1 gene polymorphisms in the development and progression of retinopathy of prematurity"],"prefix":"10.1186","volume":"23","author":[{"given":"Aneta","family":"Chor\u0119ziak-Michalak","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Gotz-Wi\u0119ckowska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Chmielarz-Czarnoci\u0144ska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agnieszka","family":"Seremak-Mrozikiewicz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dawid","family":"Szpecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,2,24]]},"reference":[{"key":"2810_CR1","doi-asserted-by":"publisher","unstructured":"Chan-Ling T, Gole GA, Quinn GE, Adamson SJ, Darlow BA. \u201cPathophysiology, screening and treatment of ROP: A multi-disciplinary perspective,\u201d Progress in Retinal and Eye Research, vol.\u00a062. Elsevier Ltd, pp.\u00a077\u2013119, Jan. 01, 2018. https:\/\/doi.org\/10.1016\/j.preteyeres.2017.09.002.","DOI":"10.1016\/j.preteyeres.2017.09.002"},{"key":"2810_CR2","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/B978-0-7020-6616-0.00044-X","volume-title":"Taylor and Hoyt\u2019s Paediatric Ophthalmology and Strabismus","author":"GE Quinn","year":"2017","unstructured":"Quinn GE, Fielder AR. \u201cRetinopathy of prematurity. In: Taylor D, Hoyt C, and, editors. \u201d in Taylor and Hoyt\u2019s Paediatric Ophthalmology and Strabismus. Eds. New York: Elsevier Saunders; 2017. pp. 443\u201355."},{"key":"2810_CR3","doi-asserted-by":"publisher","unstructured":"Swan R et al. \u201cThe Genetics of Retinopathy of Prematurity: A Model for Neovascular Retinal Disease,\u201d Ophthalmol Retina, vol.\u00a02, no. 9, pp.\u00a0949\u2013962, Sep. 2018, https:\/\/doi.org\/10.1016\/j.oret.2018.01.016.","DOI":"10.1016\/j.oret.2018.01.016"},{"key":"2810_CR4","doi-asserted-by":"publisher","unstructured":"Fevereiro-Martins M, Guimar\u00e3es H, Marques-Neves C, Bicho M. \u201cRetinopathy of prematurity: contribution of inflammatory and genetic factors,\u201d Mol Cell Biochem, vol.\u00a0477, no. 6, pp.\u00a01739\u20131763, Jun. 2022, https:\/\/doi.org\/10.1007\/s11010-022-04394-4.","DOI":"10.1007\/s11010-022-04394-4"},{"key":"2810_CR5","doi-asserted-by":"publisher","unstructured":"Hartnett ME, Penn JS. \u201cMechanisms and Management of Retinopathy of Prematurity,\u201d New England Journal of Medicine, vol.\u00a0367, no. 26, pp.\u00a02515\u20132526, Dec. 2012, https:\/\/doi.org\/10.1056\/NEJMra1208129.","DOI":"10.1056\/NEJMra1208129"},{"key":"2810_CR6","doi-asserted-by":"publisher","unstructured":"Cavallaro G, et al. The pathophysiology of retinopathy of prematurity: an update of previous and recent knowledge. Acta Ophthalmol. Feb. 2014;92(1):2\u201320. https:\/\/doi.org\/10.1111\/aos.12049.","DOI":"10.1111\/aos.12049"},{"key":"2810_CR7","doi-asserted-by":"publisher","unstructured":"Warner TD, \u201cRELATIONSHIPS BETWEEN THE ENDOTHELIN AND NITRIC OXIDE PATHWAYS. \u201d Clin Exp Pharmacol Physiol. Mar. 1999;26(3):247\u201352. https:\/\/doi.org\/10.1046\/j.1440-1681.1999.03025.x.","DOI":"10.1046\/j.1440-1681.1999.03025.x"},{"key":"2810_CR8","doi-asserted-by":"publisher","unstructured":"Yanagisawa M et al. \u201cA novel potent vasoconstrictor peptide produced by vascular endothelial cells,\u201d Nature, vol.\u00a0332, no. 6163, pp.\u00a0411\u2013415, Mar. 1988, https:\/\/doi.org\/10.1038\/332411a0.","DOI":"10.1038\/332411a0"},{"key":"2810_CR9","doi-asserted-by":"publisher","unstructured":"Pollock JS, Pollock DM. Endothelin and NOS1\/nitric oxide signaling and regulation of sodium homeostasis. Curr Opin Nephrol Hypertens. Jan. 2008;17(1):70\u20135. https:\/\/doi.org\/10.1097\/MNH.0b013e3282f34b02.","DOI":"10.1097\/MNH.0b013e3282f34b02"},{"key":"2810_CR10","doi-asserted-by":"publisher","unstructured":"Liu S, Premont RT, Kontos CD, Huang J, Rockey DC. \u201cEndothelin-1 Activates Endothelial Cell Nitric-oxide Synthase via Heterotrimeric G-protein \u03b2\u03b3 Subunit Signaling to Protein Kinase B\/Akt,\u201d Journal of Biological Chemistry, vol.\u00a0278, no. 50, pp.\u00a049929\u201349935, Dec. 2003, https:\/\/doi.org\/10.1074\/jbc.M306930200.","DOI":"10.1074\/jbc.M306930200"},{"issue":"2","key":"2810_CR11","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.artres.2011.03.003","volume":"5","author":"M Demosthenous","year":"2011","unstructured":"Demosthenous M, Antoniades C, Tousoulis D, Margaritis M, Marinou K, Stefanadis C. Endothelial nitric oxide synthase in the vascular wall: mechanisms regulating its expression and enzymatic function. Artery Res. 2011;5(2):37. https:\/\/doi.org\/10.1016\/j.artres.2011.03.003.","journal-title":"Artery Res"},{"key":"2810_CR12","doi-asserted-by":"publisher","unstructured":"Ahmed M, Rghigh A. \u201cPolymorphism in Endothelin-1 Gene: An Overview,\u201d Curr Clin Pharmacol, vol.\u00a011, no. 3, pp.\u00a0191\u2013210, Sep. 2016, https:\/\/doi.org\/10.2174\/1574884711666160701000900.","DOI":"10.2174\/1574884711666160701000900"},{"key":"2810_CR13","doi-asserted-by":"publisher","unstructured":"Stow LR, Jacobs ME, Wingo CS, Cain BD. \u201cEndothelin-1 gene regulation,\u201d The FASEB Journal, vol.\u00a025, no. 1, pp.\u00a016\u201328, Jan. 2011, https:\/\/doi.org\/10.1096\/fj.10-161612.","DOI":"10.1096\/fj.10-161612"},{"issue":"1","key":"2810_CR14","doi-asserted-by":"publisher","first-page":"14","DOI":"10.5114\/ko.2020.94207","volume":"2020","author":"A Gotz-Wi\u0119ckowska","year":"2020","unstructured":"Gotz-Wi\u0119ckowska A, Bakunowicz-\u0141azarczyk A, Hautz W, Filipek E, Niwald AM. Polish Ophthalmological Society revised guidelines for the management of retinopathy of prematurity. Klin Oczna. 2020;2020(1):14\u20136. https:\/\/doi.org\/10.5114\/ko.2020.94207.","journal-title":"Klin Oczna"},{"key":"2810_CR15","doi-asserted-by":"publisher","unstructured":"\u201cThe International Classification of Retinopathy of Prematurity Revisited,\u201d. Arch Ophthalmol. Jul. 2005;123(7):991. https:\/\/doi.org\/10.1001\/archopht.123.7.991.","DOI":"10.1001\/archopht.123.7.991"},{"key":"2810_CR16","doi-asserted-by":"publisher","unstructured":"Chiang MF et al. \u201cInternational Classification of Retinopathy of Prematurity, Third Edition,\u201d Ophthalmology, vol.\u00a0128, no. 10, pp. e51\u2013e68, Oct. 2021, https:\/\/doi.org\/10.1016\/j.ophtha.2021.05.031.","DOI":"10.1016\/j.ophtha.2021.05.031"},{"key":"2810_CR17","doi-asserted-by":"publisher","unstructured":"\u201cRevised Indications for the Treatment of Retinopathy of Prematurity,\u201d. Arch Ophthalmol. Dec. 2003;121(12):1684. https:\/\/doi.org\/10.1001\/archopht.121.12.1684.","DOI":"10.1001\/archopht.121.12.1684"},{"key":"2810_CR18","doi-asserted-by":"publisher","unstructured":"Kim SJ, Port AD, Swan R, Campbell JP, Chan RVP, Chiang MF. \u201cRetinopathy of prematurity: a review of risk factors and their clinical significance,\u201d Surv Ophthalmol, vol.\u00a063, no. 5, pp.\u00a0618\u2013637, Sep. 2018, https:\/\/doi.org\/10.1016\/j.survophthal.2018.04.002.","DOI":"10.1016\/j.survophthal.2018.04.002"},{"key":"2810_CR19","doi-asserted-by":"publisher","unstructured":"Robbins RA, Grisham MB. Nitric oxide. Int J Biochem Cell Biol. Jun. 1997;29(6):857\u201360. https:\/\/doi.org\/10.1016\/S1357-2725(96)00167-7.","DOI":"10.1016\/S1357-2725(96)00167-7"},{"key":"2810_CR20","doi-asserted-by":"publisher","unstructured":"Yanamandra K, Napper D, Pramanik A, Bocchini JA, Dhanireddy R. \u201cEndothelial Nitric Oxide Synthase genotypes in the etiology of retinopathy of prematurity in premature infants,\u201d Ophthalmic Genet, vol.\u00a031, no. 4, pp.\u00a0173\u2013177, Dec. 2010, https:\/\/doi.org\/10.3109\/13816810.2010.497528.","DOI":"10.3109\/13816810.2010.497528"},{"key":"2810_CR21","unstructured":"Yu C, Yi J, Yin X, Deng Y, Liao Y, Li X. \u201cCorrelation of interactions between NOS3 polymorphisms and oxygen therapy with retinopathy of prematurity susceptibility,\u201d 2015. [Online]. Available: www.ijcep.com\/"},{"issue":"6","key":"2810_CR22","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1080\/13816810.2021.1961279","volume":"42","author":"S Ilguy","year":"2021","unstructured":"Ilguy S, et al. The relationship of retinopathy of prematurity with brain-derivated neurotrophic factor, vascular endotelial growth factor-A, endothelial PAD domain protein 1 and nitric oxide synthase 3 gene polymorphisms. Ophthalmic Genet. 2021;42(6):725\u201331. https:\/\/doi.org\/10.1080\/13816810.2021.1961279.","journal-title":"Ophthalmic Genet"},{"key":"2810_CR23","doi-asserted-by":"publisher","unstructured":"Poggi C et al. \u201cGenetic Contributions to the Development of Complications in Preterm Newborns,\u201d PLoS One, vol.\u00a010, no. 7, p. e0131741, Jul. 2015, https:\/\/doi.org\/10.1371\/journal.pone.0131741.","DOI":"10.1371\/journal.pone.0131741"},{"key":"2810_CR24","unstructured":"Rusai K et al. \u201cEndothelial nitric oxide synthase gene T-786\u00a0C and 27-bp repeat gene polymorphisms in retinopathy of prematurity.,\u201d Mol Vis, vol.\u00a014, pp.\u00a0286\u201390, Feb. 2008."},{"key":"2810_CR25","doi-asserted-by":"publisher","unstructured":"Gohari M et al. \u201cAssociation of eNOS and ACE Polymorphisms with Retinopathy of Prematurity: A Systematic Review and Meta-Analysis,\u201d Fetal and Pediatric Pathology, vol.\u00a039, no. 4. Taylor and Francis Ltd, pp.\u00a0334\u2013345, Jul. 03, 2020. https:\/\/doi.org\/10.1080\/15513815.2019.1652378.","DOI":"10.1080\/15513815.2019.1652378"},{"key":"2810_CR26","doi-asserted-by":"publisher","unstructured":"Li J, Yin W, Liu M-S, Mao L-J, Wang X-H. \u201cPotential correlation between EDN1 gene polymorphisms with preeclampsia.,\u201d Eur Rev Med Pharmacol Sci, vol.\u00a024, no. 4, pp.\u00a01602\u20131608, Feb. 2020, https:\/\/doi.org\/10.26355\/eurrev_202002_20334.","DOI":"10.26355\/eurrev_202002_20334"},{"key":"2810_CR27","doi-asserted-by":"publisher","unstructured":"Szpecht D, Gadzinowski J, Seremak-Mrozikiewicz A, Kurzawi\u0144ska G, Szymankiewicz M. \u201cRole of endothelial nitric oxide synthase and endothelin-1 polymorphism genes with the pathogenesis of intraventricular hemorrhage in preterm infants,\u201d Sci Rep, vol.\u00a07, no. 1, p.\u00a042541, Mar. 2017, https:\/\/doi.org\/10.1038\/srep42541.","DOI":"10.1038\/srep42541"},{"key":"2810_CR28","doi-asserted-by":"publisher","unstructured":"Kim SJ, et al. Identification of candidate genes and pathways in retinopathy of prematurity by whole exome sequencing of preterm infants enriched in phenotypic extremes. Sci Rep. Mar. 2021;11(1):4966. https:\/\/doi.org\/10.1038\/s41598-021-83552-y.","DOI":"10.1038\/s41598-021-83552-y"}],"container-title":["BMC Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12886-023-02810-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12886-023-02810-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T18:15:05Z","timestamp":1701972905000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcophthalmol.biomedcentral.com\/articles\/10.1186\/s12886-023-02810-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2,24]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2810"],"URL":"https:\/\/doi.org\/10.1186\/s12886-023-02810-x","relation":{},"ISSN":["1471-2415"],"issn-type":[{"value":"1471-2415","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,2,24]]},"assertion":[{"value":"27 December 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Bioethics Committee of Poznan University of Medical Sciences (45\/22 and 126\/22) and all methods were performed in accordance with Declaration of Helsinki. Written informed consent was obtained from the parents or guardians of patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards and consent to participate"}},{"value":"Not required.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial competing interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"78"}}